The influence of microscopic inflammation at resection margins on early postoperative endoscopic recurrence after ileocaecal re-section for Crohn’s disease

Stáhnout PDF English version

Autoři: Poredská K. ¹; Kunovsky L. ^1,2; Marek F. ²; Kala Z. ²; Prochazka V. ²; Dolina J. ¹; Zboril V. ¹; Kovalcikova P. ³; Pavlik T. ³; Ja-Bandziev P. ⁴; Pavlovsky Z. ⁵; Vlazny J. ⁵; Mitas L. ²
Působiště autorů: Department of Gastroenterology and Internal Medicine, University Hospital Brno, Faculty of Medicine, Masaryk University, Brno, Czech Republic ¹; Department of Surgery, University Hospital Brno, Faculty of Medicine, Masaryk University, Brno, Czech Republic ²; Institute of Biostatistics and Analyses, Faculty of Medicine, Masaryk University, Brno, Czech Republic ³; Department of Pediatrics, University Hospital Brno, Faculty of Medicine, Masaryk University, Brno, Czech Republic ⁴; Department of Pathology, University Hospital Brno, Faculty of Medicine, Masaryk University, Brno, Czech Republic ⁵
Vyšlo v časopise: Gastroent Hepatol 2021; 75(1): 29-37
Kategorie: IBD: Originální článek

Souhrn

Background and Aims: The pathogenesis and risk factors for early postoperative endoscopic recurrence of Crohn’s disease (CD) remain unclear. Thus, this study aimed to identify whether histological inflammation at the resection margins after an ileocaecal resection influences endoscopic recurrence.

Methods: We have prospectively followed up patients with CD who underwent ileocaecal resection at our hospital between January 2012 and January 2018. The specimens were histologically analysed for inflammation at both of the resection margins (ileal and colonic). We evaluated whether histological results of the resection margins are correlated with endoscopic recurrence of CD based on colonoscopy 6 months after ileocaecal resection. Second, we assessed the influence of known risk factors and preoperative therapy on endoscopic recurrence of CD.

Results: A total of 107 patients were included in our study. Six months after ileocaecal resection, 23 patients (21.5%) had an endoscopic recurrence of CD. The histological signs of CD at the resection margins were associated with a higher endoscopic recurrence (56.5% versus 4.8%, p < 0.001). Disease duration from diagnosis to surgery (p = 0.006) and the length of the resected bowel (p = 0.019) were significantly longer in patients with endoscopic recurrence. Smoking was also proved to be a risk factor for endoscopic recurrence (p = 0.028).

Conclusions: Histological inflammation at the resection margins was significantly associated with a higher risk of early postoperative endoscopic recurrence after an ileocaecal resection for CD.

Klíčová slova:

Crohn’s disease – ileocaecal resection – early postoperative endoscopic recurrence

Zdroje

1. Bobanga ID, Bai S, Swanson MA et al. Factors influencing disease recurrence after ileocolic resection in adult and pediatric onset Crohn’s disease. Am J Surg 2014; 208(4): 591–596. doi: 10.1016/ j.amjsurg.2014.06.008.

2. De Cruz P, Kamm MA, Prideaux L et al. Postoperative recurrent luminal Crohn’s disease: a systematic review. Inflamm Bowel Dis 2012; 18(4): 758–777. doi: 10.1002/ ibd.21825.

3. Rutgeerts P, Geboes K, Vantrappen G et al. Predictability of the postoperative course of Crohn’s disease. Gastroenterology 1990; 99(4): 956–963. doi: 10.1016/ 0016-5085(90)90613-6.

4. Gionchetti P, Dignass A, Danese S et al. ECCO. Third European evidence-based consensus on the diagnosis and management of Crohn’s disease 2016: Part 2: surgical management and special situations. J Crohns Colitis 2017; 11(2): 135–149. doi: 10.1093/ ecco-jcc/ jjw169.

5. Bemelman WA, Warusavitarne J, Sampietro GM et al. ECCO-ESCP consensus on surgery for Crohn’s disease. J Crohns Colitis 2018; 12(1): 1–16. doi: 10.1093/ ecco-jcc/ jjx061.

6. Hay I, Lynch L, Saffouri E et al. AODTU-010 ileal inflammation at the resection margin is associated with an increased risk of recurrence of post-operative ileal Crohn’s disease over a 10-year follow up. Gut 2017; 66: A50. doi: 10.1136/ gutjnl-2017-314472.95.

7. Amesfoort J, Koens L, Bemelman W et al. The prognostic impact of radical resection margins on the recurrence of Crohn’s disease. J Crohns Colitis 2017; 11(Suppl 1): S412–S413. doi: 10.1093/ ecco-jcc/ jjx002.774.

8. Yamamoto T, Watanabe T. Strategies for the prevention of postoperative recurrence of Crohn’s disease. Colorectal Dis 2013; 15(12): 1471–1480. doi: 10.1111/ codi.12326.

9. Fornaro R, Caratto E, Caratto M et al. Post-operative recurrence in Crohn’s disease. Critical analysis of potential risk factors. An update. Surgeon 2015; 13(6): 330–347. doi: 10.1016/ j.surge.2015.04.002.

10. Bordeianou L, Stein SL, Ho VP et al. Immediate versus tailored prophylaxis to prevent symptomatic recurrences after surgery for ileocecal Crohn’s disease? Surgery 2011; 149(1): 72–78. doi: 10.1016/ j.surg.2010.03.009.

11. Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 2004; 240(2): 205–213. doi: 10.1097/ 01.sla.0000133083.54934.ae.

12. Sturm A, Maaser C, Calabrese E et al. European Crohn’s and Colitis Organisation (ECCO) and the European Society of Gastrointestinal and Abdominal Radiology (ESGAR). ECCO-ESGAR guideline for diagnostic assessment in IBD Part 2: IBD scores and general principles and technical aspects. J Crohns Colitis 2019; 13(3): 273–284. doi: 10.1093/ ecco-jcc/ jjy114.

13. Rutgeerts P, Geboes K, Vantrappen G et al. Natural history of recurrent Crohn’s disease at the ileocolonic anastomosis after curative surgery. Gut 1984; 25(6): 665–672. doi: 10.1136/ gut. 25.6.665.

14. De Cruz P, Kamm MA, Hamilton AL et al. Efficacy of thiopurines and adalimumab in preventing Crohn’s disease recurrence in high-risk patients – a POCER study analysis. Aliment Pharmacol Ther 2015; 42(7): 867–879. doi: 10.1111/ apt.13353.

15. Singh S, Garg SK, Pardi DS et al. Comparative efficacy of pharmacologic interventions in preventing relapse of Crohn’s disease after surgery: a systematic review and network meta-analysis. Gastroenterology 2015; 148(1): 64–76.e2. doi: 10.1053/ j.gastro.2014.09.031.

16. De Cruz P, Kamm MA, Hamilton AL et al. Crohn’s disease management after intestinal resection: a randomised trial. Lancet 2015; 385(9976): 1406–1417. doi: 10.1016/ S0140-6736(14)61908-5.

17. Yamamoto T, Keighley MR. The association of cigarette smoking with a high risk of recurrence after ileocolonic resection for ileocecal Crohn’s disease. Surg Today 1999; 29(6): 579–580. doi: 10.1007/ BF02482360.

18. Botti F, Carrara A, Antonelli B et al. The minimal bowel resection in Crohn’s disease: analysis of prognostic factors on the surgical recurrence. Ann Ital Chir 2003; 74(6): 627–633.

19. Fazio VW, Marchetti F, Church M et al. Effect of resection margins on the recurrence of Crohn’s disease in the small bowel. A randomized controlled trial. Ann Surg 1996; 224(4): 563–571: discussion 571–573. doi: 10.1097/ 000 00658-199610000-00014.

20. Fazio VW, Marchetti F. Recurrent Crohn’s disease and resection margins: bigger is not better. Adv Surg 1999; 32: 135–168.

21. Kotanagi H, Kramer K, Fazio VW et al. Do microscopic abnormalities at resection margins correlate with increased anastomotic recurrence in Crohn’s disease? Retrospective analysis of 100 cases. Dis Colon Rectum 1991; 34(10): 909–916. doi: 10.1007/ BF02049707.

22. Cunningham MF, Docherty NG, Coffey JC et al. Postsurgical recurrence of ileal Crohn’s disease: an update on risk factors and intervention points to a central role for impaired host-microflora homeostasis. World J Surg 2010; 34(7): 1615–1626. doi: 10.1007/ s00268-010-0504-6.

23. Simillis C, Yamamoto T, Reese GE et al. A meta-analysis comparing incidence of recurrence and indication for reoperation after surgery for perforating versus nonperforating Crohn’s disease. Am J Gastroenterol 2008; 103(1): 196–205. doi: 10.1111/ j.1572-0241.2007.01548.x.

24. Lemmens B, de Buck van Overstraeten A, Arijs I et al. Submucosal plexitis as a predictive factor for postoperative endoscopic recurrence in patients with Crohn’s disease undergoing a resection with ileocolonic anastomosis: results from a prospective single-centre study. J Crohns Colitis 2017; 11(2): 212–220. doi: 10.1093/ ecco-jcc/ jjw135.

25. Rutgeerts P, Van Assche G, Vermeire S et al. Ornidazole for prophylaxis of postoperative Crohn’s disease recurrence: a randomized, double-blind, placebo-controlled trial. Gastroenterology 2005; 128(4): 856–861. doi: 10.1053/ j.gastro.2005.01.010.

26. Doherty G, Bennett G, Patil S et al. Interventions for prevention of post-operative recurrence of Crohn’s disease. Cochrane Database Syst Rev 2009; 4: CD006873. doi: 10.1002/ 1465 1858.CD006873.